or Try an Advanced Search...

    Cd20 Stocks List

    Symbol Grade Name % Change
    BIIB F Biogen Idec Inc. -0.07
    GMAB F Genmab A/S 0.88
    TGTX B TG Therapeutics, Inc. 1.51
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Long-Term Care Facilities
    Related Stock Lists: Lymphoma Monoclonal Antibodies Monoclonal Antibody Antibody Drug Conjugate Biotechnology Camidanlumab Tesirine Cancer Chronic Lymphocytic Leukemia Immunology Lymphocytic Leukemia Medicine Multiple Sclerosis Treatment Of Cancer Acute Myeloid Leukemia Advanced Cancer Advanced Cancers Alzheimer's Disease Amyloid Amyloidosis Antibodies

    Related ETFs - A few ETFs which own one or more of the above listed Cd20 stocks.

    Symbol Grade Name Weight
    PBE C PowerShares Dynamic Biotech & Genome 7.99
    BIS C ProShares UltraShort Nasdaq Biotechnology 6.12
    FBT C First Trust Amex Biotech Index Fund 5.99
    BBH D Market Vectors Biotech ETF 3.89
    XBI D SPDR S&P Biotech ETF 3.81
    View all Cd20 ETFs...
    Compare ETFs
    Compare BIS to FBT Compare PBE to BIS Compare PBE to FBT

        Cd20 Stocks Recent News

        Date Stock Title
        Nov 22 BIIB Goldman Sachs: Biogen Inc. (BIIB) Is A Top Growth Investor Stock
        Nov 22 BIIB Biogen price target lowered to $207 from $251 at Mizuho
        Nov 21 GMAB Why Is Genmab A/S (GMAB) Among the Worst Performing Biotech Stocks in 2024?
        Nov 21 TGTX TG Therapeutics Ranked Number One Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™
        Nov 20 BIIB Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside
        Nov 20 BIIB Biogen Inc. (BIIB): Among the Best Genomics Stocks to Buy Right Now
        Nov 19 BIIB Biogen, UCB release phase 3 data on lupus candidate dapirolizumab
        Nov 19 BIIB Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity
        Nov 18 BIIB Biogen's Outlook Dims As Analyst Projects Flat Revenue Until 2026
        Nov 18 BIIB Needham downgrades Biogen on slow growth of Alzheimer's drug
        Nov 18 BIIB Biogen cut to hold by Needham on lack of catalysts, slow Leqembi sales
        Nov 18 BIIB Samsung Bioepis and Biogen Receive European Commission (EC) Approval for Aflibercept Biosimilar, OPUVIZ™
        Nov 18 BIIB Is Biogen Inc. (BIIB) A Cheap NASDAQ Stock To Invest In Now?
        Related Industries: Biotechnology Drug Manufacturers - Major Long-Term Care Facilities
        Related Stock Lists: Lymphoma Monoclonal Antibodies Monoclonal Antibody Antibody Drug Conjugate Biotechnology Camidanlumab Tesirine Cancer Chronic Lymphocytic Leukemia Immunology Lymphocytic Leukemia Medicine Multiple Sclerosis Treatment Of Cancer Acute Myeloid Leukemia Advanced Cancer Advanced Cancers Alzheimer's Disease Amyloid Amyloidosis Antibodies
        Cd20

        Browse All Tags